Navigation Links
Respironics to Webcast Fiscal 2008 First Quarter Conference Call
Date:10/17/2007

ss of the Company's marketing, sales, and promotion programs; future sales, acceptance, and quality of the Company's products and programs; the results of clinical trials; the timing and success of new product introductions; new product development; anticipated cost savings; FDA and other regulatory requirements, enforcement actions, product recalls or related field actions; future results from acquisitions and strategic investments; growth rates in foreign markets; regulations and other factors affecting operations and sales outside the United States; foreign currency fluctuations; the effects of a major natural disaster, cyber-attack or other catastrophic event that results in the destruction or disruption of any critical business or information technology systems; customer consolidation and concentration; increasing price competition and other competitive factors in the manufacture, distribution, and sale of products; interest rate fluctuations; expiration of intellectual property rights; intellectual property and related litigation; other litigation; future levels of earnings and revenues; the number of equity awards granted to employees and changes in the Company's stock price; and third party reimbursement; all of which are subject to change. Actual results may differ materially from those described in any forward-looking statements. Additional information on potential factors that could affect the Company's financial results are included in the reports filed with the SEC, including the reports on Form 10-K, 10-Q and 8-K.

(C) 2007 Respironics, Inc. and its affiliates. All rights reserved.


'/>"/>
SOURCE Respironics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Sonic Foundry to Webcast Bridge Arch Floating Down Mississippi
2. BoneCare doubles options and profits as fiscal year closes
3. Sonic Foundry Reports Fiscal 2003 Results
4. The Genesis of Gendicine: The Story Behind the First Gene Therapy
5. Midwest life science stocks sizzle in a tepid first quarter
6. Morgridge Institute for Research seeks first CEO
7. Sonic Foundry reports first cash-positive quarter
8. Angel investors commit $12.7B in first half of `06
9. Aurora team implants Wisconsins first total artificial heart
10. First half of 2006 roundup: Big Pharma trumps biotech
11. GE announces first installation of Discovery VCT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... , September 2, 2015 ... the winners of the 2015 BeHEARD science challenge, a ... offers rare disease researchers, access to the latest life ... its drug repositioning and pathway analytics capability to support ... Nation Foundation in the study of Niemann-Pick Disease Type ...
(Date:9/2/2015)... 2, 2015 Aytu BioScience, Inc. (OTCQB: AYTU), ... urological and related conditions, announced today that it has ... convertible note financing, raising a total of $5.175 million, ... million. Josh Disbrow , Chief ... placement are intended to be used to conduct clinical ...
(Date:9/2/2015)... , September 2, 2015 ... Gewinner des Wettbewerbs BeHEARD von 2015 bekanntgeben zu ... vom Rare Genomics Institute. Biovista unterstützt ... Medikamenten für die Behandlung anderer Krankheiten als denen, ... Steven Laffoon und sein Team bei der ...
(Date:9/2/2015)... ... September 02, 2015 , ... The TS5-Q is ... commercial video content, to analysis of athletic performance. Producing high-resolution slow-motion video ... too quickly to process with the naked eye. , Slow motion sequences ...
Breaking Biology Technology:Biovista Sponsors Wylder Nation Foundation's Research on Acid Sphingomyelinase Deficiency 2Aytu BioScience Completes $5.175 Million Private Placement 2Aytu BioScience Completes $5.175 Million Private Placement 3Biovista sponsert die Forschung von Wylder Nation Foundation zum Thema Mangel an saurer Sphingomyelinase 2Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 2Fastec Introduces the Quad-HD TS5-Q High-Speed Camera 3
... April 14, 2011 Halozyme Therapeutics, Inc. (Nasdaq: ... in type 1 diabetes patients who receive ... that Aspart-PH20, a formulation of Halozyme,s rHuPH20 (recombinant human ... absorption and shortened its duration of action. These preliminary ...
... WALTHAM, Mass., April 14, 2011 Proteon Therapeutics, ... clinical study of its lead product, PRT-201, in chronic ... (AVF) creation in preparation for hemodialysis. This study follows ... study of PRT-201 in AVF patients that completed enrollment ...
... QRxPharma Limited (ASX: QRX and OTCQX: ... Trademark Office (USPTO) issued the Company a new patent, ... covers a proprietary dosing algorithm for converting patients from ... more effectively and safely managing acute pain following surgery. ...
Cached Biology Technology:Halozyme's Ultrafast Insulin Generates Faster-In and Faster-Out Profile for Type 1 Diabetes Patients Using Insulin Pumps 2Halozyme's Ultrafast Insulin Generates Faster-In and Faster-Out Profile for Type 1 Diabetes Patients Using Insulin Pumps 3Halozyme's Ultrafast Insulin Generates Faster-In and Faster-Out Profile for Type 1 Diabetes Patients Using Insulin Pumps 4Proteon Therapeutics Initiates Patient Enrollment in Phase 2 Clinical Study of PRT-201 in Hemodialysis Patients 2U.S. Patent and Trademark Office (USPTO) Issues QRxPharma a New Patent for MoxDuo® IR; Extends Patent Coverage to 2029 2U.S. Patent and Trademark Office (USPTO) Issues QRxPharma a New Patent for MoxDuo® IR; Extends Patent Coverage to 2029 3
(Date:7/31/2015)... juli 2015 Den 10. internationale konference om ... den 22. - 25. oktober i Shenzhen ... 10-års fødselsdag i år. Siden starten i 2006 er ... på ,omik,-feltet, og er en af de mest dynamiske, ... fokuserer på nylige gennembrud og fremskridt inden for ,omik,-forskning, ...
(Date:7/31/2015)... China , 31 de julho de 2015 /PRNewswire/ ... (ICG-10, www.icg-10.org ) será realizada pela BGI de 22-25 ... . A conferência está celebrando seu ... em 2006, a ICG se tornou uma das reuniões ... um dos encontros científicos mais dinâmicos, entusiastas e prazerosos. ...
(Date:7/31/2015)... 31 de julio de 2015 La 10 th ... celebrará por medio de BGI del 22 al 25 de octubre ... Este año, la conferencia celebra su décimo aniversario. ... convertido en una de las reuniones anuales más influyentes del ... las reuniones más dinámicas, entusiastas y mejores a nivel científico. ...
Breaking Biology News(10 mins):Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3
... of researchers from the Boston University Schools of Public Health ... linked to immune function and DNA repair, that are factors ... the cessation of reproductive function of the ovaries -- is ... are in their early 50s. Most prior studies of the ...
... are pointing to new ways to save and protect today,s ... at a time of huge change in the Earth,s systems. ... and corals developed relatively recently in geological terms and ... says Professor David Bellwood of the ARC Centre of Excellence ...
... ) have not only lost their sight but have ... (albinism) and having altered sleep patterns. New research published ... Biology shows that the cavefish are an example ... losing their sight and pigmentation. The blind cavefish ...
Cached Biology News:BU study finds new genetic loci associated with menopause onset 2Lessons in coral reef survival from deep time 2Advantages of living in the dark: The multiple evolution events of 'blind' cavefish 2Advantages of living in the dark: The multiple evolution events of 'blind' cavefish 3
... kit is designed for easy transformation of ... allows for successful transformation simply by mixing ... with cultured yeast cells. No complicated steps, ... required. The kit is particularly well suited ...
... own microplate stacker system, offers fast and ... host devices:, , Ultra Evolution , SAFIRE ... and SpectraFluor Plus , LS Series of ... supporting a wide range of detection and ...
... The STag Purification Kits enable rapid analytical ... fusion proteins produced from appropriate vectors. Sufficient ... to 1 mg target protein under native ... with S-protein Agarose, which specifically retains STag ...
High affinity antibody reacting with S-100 ab heterodimer. Could be used for Western blotting application and immunoassay....
Biology Products: